Intranasal ketamine: Clinical Trials

9 trials of Intranasal ketamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 not yet recruiting, 1 suspended, 1 terminated. 9 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 4, Not yet recruiting 1, Suspended 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 12Completed 1, Not yet recruiting 1
Phase 32Unknown 1, Withdrawn 1

Follow Intranasal ketamine: new trials by email Literature Review of Intranasal ketamine trials Research Report on Intranasal ketamine

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evaluate if Intranasal Dexmedetomidine is Better Than Intranasal Ketamine in Producing Sedation and Reducing Parent Separation Anxiety Before Surgery.
Intranasal dexmedetomidine, Intranasal ketamine - Sedation, Preoperative Anxiety Experienced by the Pediatric Patient
Phase 1 / Phase 2Not yet recruitingLiaquat National Hospital & Medical College602026-01-012025-09-18
Intranasal Ketamine With Dexmedetomidine for the Treatment of Children With Autism Spectrum Disorder
ketamine and dexmedetomidine, ketamine, Saline - Autism Spectrum Disorder
Phase 2SuspendedGuangzhou Women and Children's Medical Center502018-01-202022-04-12
Intranasal (NAS) Ketamine for Cancer Pain
Intranasal ketamine - Cancer, Pain
Phase 1 / Phase 2CompletedEmory University102017-07-252021-09-09
Pain Free Laceration Repairs Using Intra-nasal Ketamine
Intranasal Ketamine - Laceration
Phase 2CompletedEvelyne D.Trottier422017-02-162019-12-16
Emergency Ketamine Treatment of Suicidal Ideation
Intranasal Ketamine, Intranasal Saline Placebo - Depression, Suicidal Ideation
Phase 2 / Phase 3UnknownUniversity of Cincinnati602016-08-012016-08-05
To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD
Ketamine, Midazolam - PTSD
Phase 2 / Phase 3WithdrawnAdriana Feder2014-12-012015-03-25
Randomized Controlled Trial of Intranasal Ketamine vs. Intranasal Midazolam in Individuals With OCD
Intranasal Ketamine, Intranasal Midazolam - Obsessive-Compulsive Disorder
Phase 2TerminatedNew York State Psychiatric Institute22014-09-012017-05-03
Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair
Intranasal ketamine - Laceration
Phase 2CompletedRhode Island Hospital452007-05-012010-07-22
Safety and Efficacy of Intranasal Ketamine for the Treatment of Postoperative Dental Pain
intranasal ketamine, placebo - Pain, Postoperative
Phase 2CompletedJavelin Pharmaceuticals402001-03-012008-02-07

Conditions studied

Agnosia (3)  ·  Lacerations (2)  ·  Autism Spectrum Disorder (1)  ·  Cancer Pain (1)  ·  Depression (1)  ·  Emergencies (1)  ·  Neoplasms (1)  ·  Obsessive-Compulsive Disorder (1)  ·  Pain (1)  ·  Pain, Postoperative (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Suicidal Ideation (1)

Sponsors

Adriana Feder (1)  ·  Emory University (1)  ·  Evelyne D.Trottier (1)  ·  Guangzhou Women and Children's Medical Center (1)  ·  Javelin Pharmaceuticals (1)  ·  Liaquat National Hospital & Medical College (1)  ·  New York State Psychiatric Institute (1)  ·  Rhode Island Hospital (1)  ·  University of Cincinnati (1)

Countries

United States (4)  ·  Canada (1)  ·  China (1)

Top investigators

Adriana Feder, MD (1)  ·  Carolyn I Rodriguez, M.D., Ph.D. (1)  ·  Cheryl McCullumsmith, MD PhD (1)  ·  Evelyne D Trottier, MD, FRCPC (1)  ·  James G Linakis, PhD, MD (1)  ·  Kyle Christensen, DDS (1)  ·  Qing Zhao, Doctor (1)  ·  Vinita Singh, MD (1)

Results publications

PMID 33583341, PMID 34928491, PMID 36774905